/www.belfasttelegraph.co.uk/news/northern-ireland/article36918586.ece/6063c/autocrop/h342/2018-05-18_new_41038410_i2.jpg.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.